Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies

Biology of Blood and Marrow Transplantation

Volumn 5, Issue 4, 1999, Pages 262-268

  Friedberg, Jonathan W ^a,b,c   Neuberg, Donna ^a   Gribben, John G ^a,b,c   Mauch, Peter ^b,c   Anderson, Kenneth C ^a,b,c   Soiffer, Robert J ^a,b,c   Takvorian, Tak ^a,b,c   Fisher, David C ^a,b,c   Schlossman, Robert ^a,b,c   Jallow, Haddie ^a   Kuhlman, Caroline ^a   Ritz, Jerome ^a,b,c   Freedman, Arnold S ^a,b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Autologous transplantation; Histologic transformation; Indolent lymphoma

Indexed keywords

ADULT; ARTICLE; AUTOTRANSPLANTATION; B CELL LYMPHOMA; BONE MARROW TRANSPLANTATION; CELL TRANSFORMATION; CLINICAL TRIAL; DRUG COMBINATION; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; BONE MARROW TRANSPLANTATION; CELL TRANSFORMATION, NEOPLASTIC; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, LOW-GRADE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RECURRENCE; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0032605410     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.1999.v5.pm10465106     Document Type: Article

References (40)

1. Horning SJ, Rosenberg SA: The natural history of initially untreated low-grade non-Hodgkin's lymphoma. N Engl J Med 311:1471, 1984.
2. Johnson P, Rohatiner A, Whelan J, Price C, Love S, Lim J, Mattews J, Norton A, Amess J, Lister T: Patterns of survival in patients with recurrent follicular lymphoma: a 20 year study from a single center. J Clin Oncol 13:140, 1995.
3. Gallagher CJ, Gregory WM, Jones AE, Stansfeld AG, Richards MA, Dhaliwal HS, Malpas JS, Lister TA: Follicular lymphoma: prognostic factors for response and survival. J Clin Oncol 4:1470, 1986.
4. Yuen A, Kamel O, Halpern J, Horning S: Long-term survival after histologic transformation of low-grade follicular lymphoma. J Clin Oncol 13:1726, 1995.
5. Richter M: Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am J Pathol 4:285, 1928.
6. Long J, Aisenberg A: Richter's syndrome. Am J Clin Pathol 63:786, 1975.
7. Armitage J, Dick F, Corder M: Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. Cancer 41:422, 1978.
8. Foucar K, Rydell R: Richter's syndrome in chronic lymphocytic leukemia. Cancer 46:118, 1980.
9. Harousseau J, Flandrin G, Tricot G, Brauet J, Seligmann M, Bernard J: Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Cancer 48:1302, 1981.
10. Robertson L, Pugh W, O'Brien S, Kantarjian H, Hirsch-Ginsberg C, Cork A, McLaughlin P, Cabanillas F, Keating M: Richter's syndrome: a report on 39 patients. J Clin Oncol 11:1985, 1993.
11. Woda B, Knowles D: Nodular lymphocytic lymphoma eventuating into diffuse histiocytic lymphoma: immunoperoxidase determination of monoclonality. Cancer 43:303, 1979.
12. Risdall R, Hoppe R, Warnke R: Non-Hodgkin's lymphoma: a study of the evolution of the disease based upon 92 autopsied cases. Cancer 44:529, 1979.
13. Trump D, Mann R, Phelps R, Roberts H, Conley C: Richter's syndrome: diffuse histiocytic lymphoma in patients with chronic lymphocytic leukemia. Am J Med 68:539, 1980.
14. Armitage JO, Dick FR, Corder MP: Diffuse histiocytic lymphoma after histologic conversion: a poor prognostic variant. Cancer Treat Rep 65:413, 1981.
15. Hubbard SM, Chabner BA, DeVita VT, Simon R, Berard CW, Jones RB, Garvin AJ, Canellos GP, Osborne CK, Young RC: Histologic progression in non-Hodgkin's lymphoma. Blood 59:258, 1982.
16. Acker B, Hoppe RT, Colby TV, Cox RS, Kaplan HS, Rosenberg SA: Histologic conversion in the non-Hodgkin's lymphomas. J Clin Oncol 1:11, 1983.
17. Garvin A, Simon R, Osborne C, Merrill J, Young R, Berard C: An autopsy study of histologic progression in non-Hodgkin's lymphomas. Cancer 52:393, 1983.
18. Oviatt D, Cousar J, Collins R, Flexner J, Stein R: Malignant lymphomas of follicular center cell origin in humans. Cancer 53:1109, 1984.
19. Bastion Y, Sebban C, Berger F, Felman P, Salles G, Dumontet C, Bryon P, Coiffier B: Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol 15:1587, 1997.
20. Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn J, Harousseau J, Coiffier B, Biron P, Mandelli F, Chauvin F: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540, 1995.
21. Schouten HC, Bierman PJ, Vanghan WP, Kessinger A, Vose JM, Weisenburger DD, Armitage JO: Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. Blood 74:2579, 1989.
22. Bastion Y, Brice P, Haioun C, Sonet A, Salles G, Marolleau J, Espinouse D, Reyes F, Gisselbrecht C, Coiffier B: Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood 86:3257, 1995.
23. Freedman AS, Ritz J, Neuberg D, Anderson KC, Rabinowe SN, Mauch P, Takvorian T, Soiffer R, Blake K, Yeap B, Coral F, Helfin L, Nadler LM: Autologous bone marrow transplantation in 69 patients with a history of low grade B cell non-Hodgkin's lymphoma. Blood 77:2524, 1991.
24. Foran J, Apostolidis J, Papamichael D, Norton A, Matthews J, Amess J, Lister T, Rohatiner A: High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre. Ann Oncol 9:865, 1998.
25. NCI: National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The non-Hodgkin's lymphoma classification project. Cancer 49:2112, 1982.
26. Harris N, Jaffe E, Stein H, Banks P, Chan J, Cleary M, Delsol G, de Wolf-Peeters C, Falini B, Gatter K, Grogan T, Isaacson P, Knowles D, Mason D, Muller-Hermelink H, Pileri S, Piris M, Ralfkiaer E, Warnke R: Perspective: a revised European American classification of lymphoid neoplasm: a proposal from the International Lymphoma Study Group. Blood 84:1361, 1994.
27. Takvorian T, Canellos GP, Ritz J, Freedman AS, Anderson KC, Mauch P, Tarbell N, Coral F, Daley H, Yeap B, Schlossman SF, Nadler LM: Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with poor prognosis. N Engl J Med 316:1499, 1987.
28. Gribben J, Freedman A, Woo S, Blake K, Shu R, G F, Longtine J, Pinkus G, Nadler L: All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275, 1991.
29. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958.
30. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163, 1966.
31. Zelenetz AD, Chen TT, Levy R: Histologic transformation of follicular lymphoma to diffuse lymphoma represents tumor progression by a single malignant B cell. J Exp Med 173:197, 1991.
32. Delsol G, Laurent G, Kuhlein E, Familiades J, Rigal F, Pris J: Richter's syndrome: evidence for the clonal origin of the two proliferations. Am Soc Clin Pathol 76:308, 1981.
33. Bertoli L, Kubagawa H, Borzillo G, Mayumi M, Prchal J, Kearney J, Durant J, Cooper M: Analysis with antiidiotype antibody of a patient with chronic lymphocytic leukemia and a large cell lymphoma (Richter's syndrome). Blood 70:45, 1987.
34. Elenitoba-Johnson K, Gascoyne R, Lim M, Lim M, Chhanabai M, Jaffe E, Raffeld M: Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood 91:4677, 1998.
35. Lo Coco F, Gaidano G, Louie D, Offit K, Chaganti R, Dalla-Favera R: p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82:2289, 1993.
36. Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A, Monconduit M, Bastard C: Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 84:1043, 1994.
37. Matolcsy A, Casali P, Warnke R, Kowles D: Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated bcl-2-gene. Blood 88:3937, 1996.
38. Stone R, Neuberg D, Soiffer R, Takvorian T, Whelan M, Rabinowe S, Aster J, Leavitt P, Mauch P, Freedman A, Nadler L: Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 12:2535, 1994.
39. Miller J, Arthur D, Litz C, Neglia J, Miller W, Weisdorf D: Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood 83:3780, 1994.
40. Darrington D, Vose J, Anderson J, Bierman P, Bishop M, Chan W, Morris M, Reed E, Sanger WG, Tarantolo S, Weisenburger D, Kessinger A, Armitage J: Incidence and characterization of secondary myelodysplastic syndrome following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol 12:2527, 1994.